SOURCE: Daxor Corp.

April 26, 2007 08:30 ET

Daxor Corporation to Present at the Taglich Brothers 4th Annual Small Cap Equity Conference

Senior Management Will Meet With Investors in New York City on May 1, 2007

NEW YORK, NY -- (MARKET WIRE) -- April 26, 2007 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced that Dr. Joseph Feldschuh, President & CEO, Stephen Feldschuh, Chief Operating Officer, & and John Reyes-Guerra, VP for Sales and Marketing, will be participating with 12 other companies in the exclusive Taglich Brothers Small Cap Equity Conference at 2:15 p.m. on May 1, 2007. The event will be held at Le Parker Meridien, New York City, where institutional investors will obtain insight into the small-cap sector through direct interaction with company management teams.

More information about the conference can be found at:

About Daxor

Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. Among nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a trial basis are The Mayo Clinic, The Cleveland Clinic and New York University Medical Center

For More Information Contact:

For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website, or contact Stephen Feldschuh, 212-330-8515 (VP of Operations) or Diane Meegan, 212-330-8512 (Investor Relations)

Contact Information